Clinical Trial Update: Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial funded by UCSF is evaluating Miraculin to alleviate taste dysfunction in head and neck cancer patients receiving radiation therapy, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Miraculin (Miraculin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Head and Neck Cancer, Taste Dysfunction | Phase 3 | Status: RECRUITING